| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCAPI1355 | Loteprednol etabonate | Loteprednol etabonate |
|
| DC9011 | Mizoribine Featured | Mizoribine(NSC 289637; HE 69; β-Bredinin) is an immunosuppressive agents (IC50=100 uM) that inhibit the proliferation of lymphocytes selectively, via inhibition of IMPDH. |
|
| DC3167 | MK0812 | MK-0812 is chemokine receptor CCR-2 antagonist |
|
| DC9279 | MK-571 Featured | MK-571 is a selective, orally active CysLT1 receptor antagonist. |
|
| DC9448 | MK591 | MK591(Quiflapon sodium) is a selective and specific 5-Lipoxygenase-activating protein (FLAP) inhibitor. |
|
| DC3160 | Montelukast Sodium Featured | Montelukast belongs to a group of medications known as leukotriene receptor antagonists. |
|
| DC7471 | N6022 Featured | N6022 is a potent, selective, reversible, and efficacious S-Nitrosoglutathione reductase(GSNOR) inhibitor(IC50=10 nM) which is currently undergoing clinical development. |
|
| DC7472 | Nedocromil | Nedocromil is an inhaled anti-inflammatory agent for the preventive management of asthma. |
|
| DC9583 | Oglemilast Featured | Oglemilast(GRC3886) is a potent PDE4 inhibitor, under clinical studies in the treatment of allergen-induced asthma. |
|
| DC10384 | Olodaterol Featured | Olodaterol (BI1744) is a long acting β2-adrenoceptor agonist with an EC50 of 1.4±0.08 nM. |
|
| DC9248 | Olodaterol(BI-1744) hydrochloride Featured | Olodaterol is a novel, long-acting beta2-adrenergic agonist (LABA) that exerts its pharmacological effect by binding and activating beta2-adrenergic receptors located primarily in the lungs. |
|
| DC8281 | Ozanimod (RPC1063) Featured | Ozanimod (RPC1063) is a selective S1P1R modulator |
|
| DC10399 | PAC-14028 | PAC-14028 is a potent and selective transient receptor potential vanilloid type I (TRPV1) antagonist. |
|
| DC9681 | Pamapimod（R-1503） Featured | Pamapimod（R-1503）is a novel p38 MAP kinase inhibitor. |
|
| DC10893 | Parimifasor Featured | Parimifasor is an immunomodulator, with anti-inflammatory activity. |
|
| DC8168 | Peficitinib（ASP015K,JNJ-54781532） Featured | Peficitinib(ASP015K,JNJ-54781532) is a novel potent JAK inhibitor, which demonstrated potent efficacy in adjuvant-induced arthritis model in rats. |
|
| DC11734 | PF-06263276 | PF-06263276 (PF06263276, PF 6263276) is a potent, selective pan JAK inhibitor with IC50 of 2.2, 23.1, 59.9 and 29.7 nM for JAK1, JAK2, JAK3, and TYK2, respectively. |
|
| DC10779 | PF-06651600 Featured | PF-06651600 is a potent JAK3-selective inhibitor with an IC50 of 33.1 nM. |
|
| DC12488 | PF-06700841 tosylate Featured | PF-06700841 is an inhibitor of JAK1 and TYK2 kinases. PF-06700841 has been investigated for the treatment of psoriasis and lupus. |
|
| DC8741 | Plerixafor octahydrochloride Featured | Plerixafor octahydrochloride(AMD3100 8HCL) is a chemokine receptor antagonist for CXCR4 and CXCL12-mediated chemotaxis with IC50 of 44 nM and 5.7 nM, respectively. |
|
| DC11373 | Polmacoxib | Polmacoxib is an inhibitor of cyclooxygenase 2 (COX-2) and the carbonic anhydrase subtypes I (CAI) and CAII. |
|
| DC9742 | Ponesimod Featured | Ponesimod(ACT-128800) is an orally active, selective sphingosine-1-phosphate receptor 1 (S1P1) immunomodulator with EC50 of 5.7 nM. |
|
| DC11914 | Poseltinib Featured | Poseltinib (HM-71224, LY-3337641) is a potent and selective, covalent inhibitor of Btk with IC50 of 1.95 nM. |
|
| DC9841 | Fostamatinib(R788) Featured | R788 (Fostamatinib), a prodrug of the active metabolite R406, is a potent Syk inhibitor with IC50 of 41 nM. |
|
| DC1013 | R788 disodium (Fostamatinib) Featured | R935788 (Fostamatinib disodium, R788) is a Syk inhibitor with IC50 of 41 nM. |
|
| DC5146 | RN486 Featured | RN-486 is a Bruton's tyrosine kinase (Btk) inhibitor. |
|
| DC11671 | RPL-554 | RPL-554 (LS-193855, RPL554) is a potent, orally available, dual PDE3/PDE4 inhibitor with IC50 of 0.4 nM and 1479 nM, respectively. |
|
| DC8436 | Salmeterol Xinafoate Featured | Salmeterol Xinafoate is a long-acting β2-adrenergic receptor agonist with anti-inflammatory effects, used in the treatment of asthma symptoms and chronic obstructive pulmonary disease (COPD) symptoms. |
|
| DC9410 | SCH 527123 | SCH-527123 is a potent antagonist of both CXCR1 and CXCR2 with IC50 of 42 nM and 3 nM, respectively. |
|
| DC10193 | Seletalisib Featured | Seletalisib (UCB5857) is potent and selective PI3Kδ inhibitor with an IC50 of 12 nM. |
|
